FDA Should Adopt FTC` Regulatory Policy For Supplement Claims, CRN Says
This article was originally published in The Tan Sheet
Executive Summary
FDA should emulate the Federal Trade Commission and focus on ensuring dietary supplements make truthful and substantiated label statements instead of worrying about what constitutes an implied disease claim, Council for Responsible Nutrition Scientific and Regulatory Affairs VP Annette Dickinson, PhD, commented at an FDA meeting on structure/function claims in Washington, D.C. Aug. 4.
You may also be interested in...
National Consumers League To Hold Dietary Supplement Roundtable Sept. 22
The National Consumers League plans to kick off a new consumer education campaign on dietary supplements with a Sept. 22 roundtable discussion featuring regulatory, industry, healthcare and consumer group representatives.
FTC Supplement Ad Guide Application "Negative" Grace Period Predicted
Application of the Federal Trade Commission's dietary supplement advertising guide likely will involve a "negative grace period," predicted D.C. attorney William MacLeod (Shannon, Scott & Rill) at the Council for Responsible Nutrition's workshop on the guide in Washington, D.C. Feb. 4.
FTC Use of Expert Opinions On Supplement Ad Claim Support Cited In Guide
A "guiding principle" in the Federal Trade Commission's determination of the amount and type of evidence needed to substantiate a dietary supplement advertising claim is "what experts in the relevant area of study would generally consider to be adequate," the commission states in a business guide for supplement advertisers released Nov. 18.